La Jolla Pharmaceutical Co (LJPC)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

4550 TOWNE CENTRE COURT SAN DIEGO, CA 92121

La Jolla Pharmaceutical is a biopharmaceutical company focused on improving and preserving human life by developing enhanced pharmaceutical products. Co.'s key product in development is Riquent, which is designed to treat lupus renal disease by preventing or delaying renal flares, suppressing the production of antibodies to double-stranded deoxyribonucleic acid (dsDNA) in lupus patients without suppressing the normal function of the immune system. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues.

Data as of 2020-05-30
Market Cap128.851 Million Shares Outstanding27.299 Million Avg 30-day Volume825.392 Thousand
P/E Ratio Dividend Yield EPS-3.45
Price/Sales4.909 Price cash flow ratio Price free cash flow ratio-2.0
Book Value-2.4 Price to Tangible Book-1.94 Alpha-0.01
Short Interest Ratio % Short Interest to Float R-squared0.146976
BETA2.50695 52-week High/Low13.9 / 2.3 Stddev0.279544
View SEC Filings from LJPC instead.

View recent insider trading info

Funds Holding LJPC (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LJPC BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

615.1 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

TANG KEVIN C

TANG CAPITAL PARTNERS LP

TANG CAPITAL MANAGEMENT LLC

HEARNE MICHAEL S CHIEF FINANCIAL OFFICER

  • Officer
  • Director
  • 10% Owner
8,695,474 2020-06-02 3

HEARNE MICHAEL S CHIEF FINANCIAL OFFICER

  • Officer
0 2020-06-01 3

MULROY DENNIS CHIEF FINANCIAL OFFICER

  • Officer
5,067 2020-05-29 19

CHAWLA LAKHMIR S CHIEF MEDICAL OFFICER

  • Officer
9,942 2020-05-29 25

ROLKE JAMES CHIEF SCIENTIFIC OFFICER

  • Officer
81,771 2020-05-29 22

TOPPER JAMES N

  • Director
  • 10% Owner
0 2020-05-21 0

SUTTER MARTIN P

  • Director
188,239 2020-05-15 0

ADAMS THOMAS PHD

  • Director
18,875 2020-05-14 0

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
55,042,456 2020-04-24 0

JOHNSON CRAIG A

2,000 2020-04-20 2

WELLINGHOFF DARRYL CHIEF COMMERCIAL OFFICER

  • Officer
9,504 2020-04-15 21

SMITH CRAIG R

  • Director
54,469 2020-03-13 0

TANG KEVIN C

TANG CAPITAL PARTNERS LP

TANG CAPITAL MANAGEMENT LLC

  • Director
  • 10% Owner
8,080,345 2020-01-30 3

TANG KEVIN C

  • Director
5,038,491 2019-12-31 3

DOUGLASS LAURA L.

  • Director
0 2019-12-20 1

ROSEN ROBERT

  • Director
0 2019-12-20 1

RAMSAY DAVID A

  • Director
0 2019-12-20 3

TIDMARSH GEORGE F

  • Director
151,291 2019-09-19 0

ZARRABIAN SAIID PRESIDENT AND CEO

  • Officer
  • Director
0 2019-09-05 0

CARVER JENNIFER CHIEF OPERATING OFFICER

  • Officer
14,049 2019-02-28 0

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

  • 10% Owner
No longer subject to file 2018-11-27 0

FRAZIER HEALTHCARE V, LP

  • 10% Owner
No longer subject to file 2016-11-01 0

LIANG BERTRAND C. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
0 2016-02-01 0

GILLESPIE DEIRDRE

  • Director
0 2016-01-04 0

FRAZIER HEALTHCARE V, LP

FHM V, LP

FHM V, LLC

  • 10% Owner
No longer subject to file 2013-09-24 0

BIOMARIN PHARMACEUTICAL INC

  • 10% Owner
6,666,667 2012-12-08 0

REINISCH RICHARD

  • INDIVIDUAL INVESTOR
1,100,000 2012-08-01 0

SLOAN GAIL A CHIEF FINANCIAL OFFICER

  • Officer
980 2011-04-20 0

FILDES ROBERT PHD

  • Director
0 2010-05-28 0

MARTIN STEPHEN

  • Director
0 2010-05-28 0

ESSEX WOODLANDS HEALTH VENTURES FUND VI L P

  • 10% Owner
2,371,642 2009-09-15 0

ELCHICO JOSEFINA T VP QUALITY OPERATIONS

  • Officer
0 2009-02-24 0

GONZALEZ ALEJANDRO

  • 10% Owner
No longer subject to file 2009-02-12 0

SEIKKULA LUKE VICE PRESIDENT MANUFACTURING

  • Officer
0 2009-01-22 0

TANSEY MICHAEL JAMES BYRON EXECUTIVE VP & CMO

  • Officer
0 2009-01-22 0

CAVIAR NIV EDWARD CHIEF BUSINESS OFFICER & CFO

  • Officer
0 2009-01-22 0

YOUNG FRANK

  • Director
0 2008-05-22 0

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5

TANG KEVIN C - Director - > 10% Owner by lp

TANG CAPITAL PARTNERS LP - > 10% Owner by lp

TANG CAPITAL MANAGEMENT LLC - > 10% Owner by lp

HEARNE MICHAEL S - Officer CHIEF FINANCIAL OFFICER by lp

2020-06-04 P 215,812 $4.94 a 8,695,474 8,695,474.00 indirect

TANG KEVIN C - Director - > 10% Owner by lp

TANG CAPITAL PARTNERS LP - > 10% Owner by lp

TANG CAPITAL MANAGEMENT LLC - > 10% Owner by lp

HEARNE MICHAEL S - Officer CHIEF FINANCIAL OFFICER by lp

2020-06-03 P 145,764 $4.90 a 8,479,662 8,695,474.00 indirect

TANG KEVIN C - Director - > 10% Owner by lp

TANG CAPITAL PARTNERS LP - > 10% Owner by lp

TANG CAPITAL MANAGEMENT LLC - > 10% Owner by lp

HEARNE MICHAEL S - Officer CHIEF FINANCIAL OFFICER by lp

2020-06-02 P 253,553 $4.88 a 8,333,898 8,695,474.00 indirect

HEARNE MICHAEL S - Officer CHIEF FINANCIAL OFFICER

2020-06-01 A 100,000 a 100,000 0.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-05-29 A 491 a 491 9,942.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-05-29 A 82 $4.01 a 5,067 5,067.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-05-29 A 205 a 205 81,771.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-05-29 A 491 $4.01 a 9,942 9,942.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-05-29 A 205 $4.01 a 81,771 81,771.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-05-29 A 82 a 82 5,067.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-05-15 A 335 a 335 9,451.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-05-15 A 56 $5.86 a 4,985 4,985.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-05-15 A 140 a 140 81,566.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-05-15 A 335 $5.86 a 9,451 9,451.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-05-15 A 140 $5.86 a 81,566 81,566.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-05-15 A 56 a 56 4,985.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-04-30 A 319 a 319 9,116.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-04-30 A 133 $6.17 a 81,426 81,426.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-04-30 A 53 a 53 4,929.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-04-30 A 319 $6.17 a 9,116 9,116.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-04-30 A 53 $6.17 a 4,929 4,929.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-04-30 A 133 a 133 81,426.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-04-15 A 58 $5.61 a 4,876 4,876.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-04-15 A 350 a 350 8,797.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2020-04-15 A 34 $5.61 a 9,504 9,504.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-04-15 A 146 a 146 81,293.00 direct

CHAWLA LAKHMIR S - Officer CHIEF MEDICAL OFFICER

2020-04-15 A 350 $5.61 a 8,797 8,797.00 direct

MULROY DENNIS - Officer CHIEF FINANCIAL OFFICER

2020-04-15 A 58 a 58 4,876.00 direct

ROLKE JAMES - Officer CHIEF SCIENTIFIC OFFICER

2020-04-15 A 146 $5.61 a 81,293 81,293.00 direct

WELLINGHOFF DARRYL - Officer CHIEF COMMERCIAL OFFICER

2020-04-15 A 34 a 34 9,504.00 direct

Elevate your investments